Flusiva is the first FDA-approved seasonal influenza vaccine to use mRNA technology. Beyond influenza itself, how significant is this approval for the future development of vaccines and infectious ...
ZME Science on MSN
The US just approved its first mRNA flu vaccine. Is this a new era?
For the first time, the United States has an mRNA flu shot. The FDA has cleared Moderna’s mFlusiva for adults aged 50 and ...
The FDA approved an mRNA seasonal influenza vaccine offering enhanced protection for adults aged 50 years or older compared with standard vaccines. The Conversation — Vaccines have been reliably and ...
The FDA approved Moderna’s flu vaccine mFLUSIVA, a regulatory decision that comes six months after the agency refused to ...
The Food and Drug Administration has approved a new influenza vaccine for older adults manufactured by Moderna. The shot ...
The efficacy of flu shots is not always the same and it’s not always optimal. Some years, they can reduce the risk of illness by as little as 20% to 30%. Messenger RNA technology, or mRNA, is widely ...
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...
Scientists have uncovered a mechanism by which human cells distinguish between more and less efficient genetic codons, revealing that the genetic code carries an additional layer of regulatory ...
Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential to significantly boost the immune system’s ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results